Reversing age-related changes in liver cells reduced circulating amyloid beta and cholesterol in rats, revealing a potential new approach to tackling age-related disease.
For 75,000 people with Huntington's disease and no approved therapy to slow it — uniQure's Priority Review marks the closest the field has come to a treatment
Investment will scale nPhase’s enterprise clinical data business and accelerate expansion of its Statistical Computing Environment (SCE), Unified Data Management System (UDMS), and agentic AI capabilities across the clinical data lifecycle.
Biomarkers could help researchers identify patients most likely to respond to psychiatric drugs, but translating early promise into clinical success remains a challenge.
Explore how surface plasmon resonance can reveal binding kinetics, epitope relationships, and receptor interactions to guide antibody lead optimization.
IVDR-certified CytoCell probes for IGH and ATM extend FISH in CLL and myeloma, filling gaps where sequencing turnaround and structural detection fall short
From automated experiments to AI-powered analysis, connected data, and smarter resource use, digital technologies are reshaping how scientists work — and what the laboratory itself can do.
From automated experiments to AI-powered analysis, connected data, and smarter resource use, digital technologies are reshaping how scientists work — and what the laboratory itself can do.
From automated experiments to AI-powered analysis, connected data, and smarter resource use, digital technologies are reshaping how scientists work — and what the laboratory itself can do.
From automated experiments to AI-powered analysis, connected data, and smarter resource use, digital technologies are reshaping how scientists work — and what the laboratory itself can do.